You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Respiratory
SOPHiA GENETICS and Synnovis partner to expand NHS liquid biopsy testing
Login
Username:

Password:


Related Headlines

European Commission approves Bristol Myers Squibb's Sotyktu for psoriatic arthritis

Chance Pharma reports NMPA acceptance of NDA for investigational respiratory drug CXG87

Racura Oncology identifies mechanism of action for (E,E)-bisantrene

Insilico's Rentosertib inhalation solution receives IND clearance to enter direct-to-lung clinical study

Xcovery and EVERSANA partner for US commmercialisation of lung cancer drug Ensacove

Cipla's AB-rated Ventolin HFA generic receives US FDA approval

Orion Pharma launches Phase 1b/2 TEADCO trial of ODM-212 in advanced solid tumours

Natera showcases Prospera transplant data across 17 presentations at ISHLT 2026

AstraZeneca reports third positive Phase III trial for tozorakimab in COPD

Accent Therapeutics presents ATX-295 data at AACR Annual Meeting 2026

Whitehawk Therapeutics presents ADC preclinical data at AACR 2026

European Commission approves Merck's ENFLONSIA for infant RSV prevention in Europe

Philips secures FDA clearance for Spectral CT Verida system

GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma

hVIVO signs influenza human challenge trial agreement with Traws Pharma

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026